{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T07:19:33Z","timestamp":1774595973003,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009281","name":"Fondation Thierry Latran","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["CSA 2012\/11"],"award-info":[{"award-number":["CSA 2012\/11"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["259867"],"award-info":[{"award-number":["259867"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["15\/SPP\/3244"],"award-info":[{"award-number":["15\/SPP\/3244"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["16\/ERCD\/3854"],"award-info":[{"award-number":["16\/ERCD\/3854"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000406","name":"Motor Neurone Disease Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000406","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014076","name":"Stichting ALS Nederland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014941","name":"Cytokinetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014941","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Neurology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/s1474-4422(18)30089-9","type":"journal-article","created":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:28:02Z","timestamp":1522110482000},"page":"423-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":463,"title":["Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model"],"prefix":"10.1016","volume":"17","author":[{"given":"Henk-Jan","family":"Westeneng","sequence":"first","affiliation":[]},{"given":"Thomas P A","family":"Debray","sequence":"additional","affiliation":[]},{"given":"Anne E","family":"Visser","sequence":"additional","affiliation":[]},{"given":"Ruben P A","family":"van Eijk","sequence":"additional","affiliation":[]},{"given":"James P K","family":"Rooney","sequence":"additional","affiliation":[]},{"given":"Andrea","family":"Calvo","sequence":"additional","affiliation":[]},{"given":"Sarah","family":"Martin","sequence":"additional","affiliation":[]},{"given":"Christopher J","family":"McDermott","sequence":"additional","affiliation":[]},{"given":"Alexander G","family":"Thompson","sequence":"additional","affiliation":[]},{"given":"Susana","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Xenia","family":"Kobeleva","sequence":"additional","affiliation":[]},{"given":"Angela","family":"Rosenbohm","sequence":"additional","affiliation":[]},{"given":"Beatrice","family":"Stubendorff","sequence":"additional","affiliation":[]},{"given":"Helma","family":"Sommer","sequence":"additional","affiliation":[]},{"given":"Bas M","family":"Middelkoop","sequence":"additional","affiliation":[]},{"given":"Annelot M","family":"Dekker","sequence":"additional","affiliation":[]},{"given":"Joke J F A","family":"van Vugt","sequence":"additional","affiliation":[]},{"given":"Wouter","family":"van Rheenen","sequence":"additional","affiliation":[]},{"given":"Alice","family":"Vajda","sequence":"additional","affiliation":[]},{"given":"Mark","family":"Heverin","sequence":"additional","affiliation":[]},{"given":"Mbombe","family":"Kazoka","sequence":"additional","affiliation":[]},{"given":"Hannah","family":"Hollinger","sequence":"additional","affiliation":[]},{"given":"Marta","family":"Gromicho","sequence":"additional","affiliation":[]},{"given":"Sonja","family":"K\u00f6rner","sequence":"additional","affiliation":[]},{"given":"Thomas M","family":"Ringer","sequence":"additional","affiliation":[]},{"given":"Annekathrin","family":"R\u00f6diger","sequence":"additional","affiliation":[]},{"given":"Anne","family":"Gunkel","sequence":"additional","affiliation":[]},{"given":"Christopher E","family":"Shaw","sequence":"additional","affiliation":[]},{"given":"Annelien L","family":"Bredenoord","sequence":"additional","affiliation":[]},{"given":"Michael A","family":"van Es","sequence":"additional","affiliation":[]},{"given":"Philippe","family":"Corcia","sequence":"additional","affiliation":[]},{"given":"Philippe","family":"Couratier","sequence":"additional","affiliation":[]},{"given":"Markus","family":"Weber","sequence":"additional","affiliation":[]},{"given":"Julian","family":"Grosskreutz","sequence":"additional","affiliation":[]},{"given":"Albert C","family":"Ludolph","sequence":"additional","affiliation":[]},{"given":"Susanne","family":"Petri","sequence":"additional","affiliation":[]},{"given":"Mamede","family":"de Carvalho","sequence":"additional","affiliation":[]},{"given":"Philip","family":"Van Damme","sequence":"additional","affiliation":[]},{"given":"Kevin","family":"Talbot","sequence":"additional","affiliation":[]},{"given":"Martin R","family":"Turner","sequence":"additional","affiliation":[]},{"given":"Pamela J","family":"Shaw","sequence":"additional","affiliation":[]},{"given":"Ammar","family":"Al-Chalabi","sequence":"additional","affiliation":[]},{"given":"Adriano","family":"Chi\u00f2","sequence":"additional","affiliation":[]},{"given":"Orla","family":"Hardiman","sequence":"additional","affiliation":[]},{"given":"Karel G M","family":"Moons","sequence":"additional","affiliation":[]},{"given":"Jan H","family":"Veldink","sequence":"additional","affiliation":[]},{"given":"Leonard H","family":"van den Berg","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1474-4422(18)30089-9_bib1","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S1474-4422(18)30089-9_bib2","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1056\/NEJMsb1503104","article-title":"Precision medicine\u2014personalized, problematic, and promising","volume":"372","author":"Jameson","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S1474-4422(18)30089-9_bib3","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S1474-4422(18)30089-9_bib4","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","article-title":"Amyotrophic lateral sclerosis","volume":"390","author":"van Es","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/S1474-4422(18)30089-9_bib5","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1212\/01.wnl.0000172911.39167.b6","article-title":"Prevalence and patterns of cognitive impairment in sporadic ALS","volume":"65","author":"Ringholz","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(18)30089-9_bib6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/17482960802566824","article-title":"Prognostic factors in ALS: a critical review","volume":"10","author":"Chio","year":"2009","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/S1474-4422(18)30089-9_bib7","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1212\/WNL.0b013e3182661d14","article-title":"Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases","volume":"79","author":"van Rheenen","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(18)30089-9_bib8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/sim.6787","article-title":"Sample size considerations for the external validation of a multivariable prognostic model: a resampling study","volume":"35","author":"Collins","year":"2016","journal-title":"Stat Med"},{"key":"10.1016\/S1474-4422(18)30089-9_bib9","doi-asserted-by":"crossref","first-page":"i3140","DOI":"10.1136\/bmj.i3140","article-title":"External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges","volume":"353","author":"Riley","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/S1474-4422(18)30089-9_bib10","doi-asserted-by":"crossref","first-page":"g7594","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"350","author":"Collins","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/S1474-4422(18)30089-9_bib11","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/jnnp.2011.244939","article-title":"Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology","volume":"82","author":"Huisman","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(18)30089-9_bib12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"10.1016\/S1474-4422(18)30089-9_bib13","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S1474-4422(13)70221-7","article-title":"Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial","volume":"12","author":"Cudkowicz","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/S1474-4422(18)30089-9_bib14","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","volume":"3","author":"Miller","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S1474-4422(18)30089-9_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1212\/01.wnl.0000194316.91908.8a","article-title":"Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS","volume":"66","author":"Kimura","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(18)30089-9_bib16","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1212\/WNL.0b013e3182840689","article-title":"Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort","volume":"80","author":"Gallo","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(18)30089-9_bib17","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1136\/jnnp-2016-313793","article-title":"Influence of cigarette smoking on ALS outcome: a population-based study","volume":"87","author":"Calvo","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(18)30089-9_bib18","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(18)30089-9_bib19","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0028-3932(99)00146-3","article-title":"Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS)","volume":"38","author":"Abrahams","year":"2000","journal-title":"Neuropsychologia"},{"key":"10.1016\/S1474-4422(18)30089-9_bib20","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","article-title":"The FAB: a Frontal Assessment Battery at bedside","volume":"55","author":"Dubois","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(18)30089-9_bib21","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1212\/WNL.0b013e31826c1aa1","article-title":"The ALS-FTD-Q: a new screening tool for behavioral disturbances in ALS","volume":"79","author":"Raaphorst","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(18)30089-9_bib22","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.neurobiolaging.2011.10.029","article-title":"UNC13A is a modifier of survival in amyotrophic lateral sclerosis","volume":"33","author":"Diekstra","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/S1474-4422(18)30089-9_bib23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1474-4422(12)70043-1","article-title":"Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study","volume":"11","author":"Majounie","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/S1474-4422(18)30089-9_bib24","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/WCO.0b013e32835a3efb","article-title":"How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders?","volume":"25","author":"van Blitterswijk","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/S1474-4422(18)30089-9_bib25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1590\/S0004-282X2013000300004","article-title":"Monitoring respiratory muscle strength assists in early diagnosis of respiratory dysfunction as opposed to the isolated use of pulmonary function evaluation in amyotrophic lateral sclerosis","volume":"71","author":"Fregonezi","year":"2013","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/S1474-4422(18)30089-9_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2288-7-33","article-title":"Variable selection under multiple imputation using the bootstrap in a prognostic study","volume":"7","author":"Heymans","year":"2007","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/S1474-4422(18)30089-9_bib27","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1002\/sim.5732","article-title":"A framework for developing, implementing, and evaluating clinical prediction models in an individual participant data meta-analysis","volume":"32","author":"Debray","year":"2013","journal-title":"Stat Med"},{"key":"10.1016\/S1474-4422(18)30089-9_bib28","doi-asserted-by":"crossref","first-page":"e1001886","DOI":"10.1371\/journal.pmed.1001886","article-title":"Individual participant data (IPD) meta-analyses of diagnostic and prognostic modeling studies: guidance on their use","volume":"12","author":"Debray","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/S1474-4422(18)30089-9_bib29","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jclinepi.2015.05.009","article-title":"Multivariate meta-analysis of individual participant data helped externally validate the performance and implementation of a prediction model","volume":"69","author":"Snell","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S1474-4422(18)30089-9_bib30","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/sim.1203","article-title":"Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects","volume":"21","author":"Royston","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/S1474-4422(18)30089-9_bib31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/1467-985X.00122","article-title":"Building multivariable prognostic and diagnostic models: transformation of the predictors by using fractional polynomials","volume":"162","author":"Sauerbrei","year":"1999","journal-title":"J R Stat Soc Series A Stats Soc"},{"key":"10.1016\/S1474-4422(18)30089-9_bib32","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1002\/sim.6837","article-title":"Multiple imputation for IPD meta-analysis: allowing for heterogeneity and studies with missing covariates","volume":"35","author":"Quartagno","year":"2016","journal-title":"Stat Med"},{"key":"10.1016\/S1474-4422(18)30089-9_bib33","doi-asserted-by":"crossref","first-page":"b2393","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls","volume":"338","author":"Sterne","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/S1474-4422(18)30089-9_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2288-13-33","article-title":"External validation of a Cox prognostic model: principles and methods","volume":"13","author":"Royston","year":"2013","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/S1474-4422(18)30089-9_bib35","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00415-015-7731-6","article-title":"Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm","volume":"262","author":"Elamin","year":"2015","journal-title":"J Neurol"},{"key":"10.1016\/S1474-4422(18)30089-9_bib36","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/21678421.2017.1285939","article-title":"Critical issues in ALS case-control studies: the case of the Euro-MOTOR study","volume":"18","author":"D'Ovidio","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/S1474-4422(18)30089-9_bib37","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/jnnp-2016-314495","article-title":"The changing picture of amyotrophic lateral sclerosis: lessons from European registers","volume":"88","author":"Hardiman","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(18)30089-9_bib38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/0269216308098799","article-title":"Advanced cancer patients' prognostic information preferences: a review","volume":"23","author":"Innes","year":"2009","journal-title":"Palliat Med"},{"key":"10.1016\/S1474-4422(18)30089-9_bib39","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1001\/jamainternmed.2014.5271","article-title":"Communication about serious illness care goals: a review and synthesis of best practices","volume":"174","author":"Bernacki","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S1474-4422(18)30089-9_bib40","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N Engl J Med"}],"container-title":["The Lancet Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1474442218300899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1474442218300899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T10:17:27Z","timestamp":1761473847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1474442218300899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1474442218300899"],"URL":"https:\/\/doi.org\/10.1016\/s1474-4422(18)30089-9","relation":{},"ISSN":["1474-4422"],"issn-type":[{"value":"1474-4422","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model","name":"articletitle","label":"Article Title"},{"value":"The Lancet Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1474-4422(18)30089-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S1474-4422(18)30111-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}